Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Obesity Treatment Center Medical Group, operating as The Hernried Center for Medical Weight Loss, is a specialized medical practice dedicated to the treatment of obesity and metabolic disorders. Founded in 1983 and led by Dr. John D. Hernried, the group provides comprehensive, medically supervised weight management programs that integrate nutritional intervention, behavioral therapy, and medical oversight. The center utilizes evidence-based protocols, including very-low-calorie diets (VLCD) and FDA-approved weight loss medications, to help patients achieve sustainable weight loss and improve obesity-related comorbidities. Their multidisciplinary team includes physicians, registered dietitians, and behavioral health specialists who focus on treating obesity as a chronic medical disease. The group is a key partner of Robard Corporation, implementing the New Direction Advanced program to provide structured meal replacement and metabolic support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Obesity Treatment Center Medical Group.